IMMUNE INSIGHTS
Imperial’s human challenge study helps explain why some people don’t get COVID
New analysis based on Imperial’s COVID-19 human challenge study has helped to uncover how some people avoid getting sick.
Imperial’s human challenge study helps explain why some people don’t get COVID
New analysis based on Imperial’s COVID-19 human challenge study has helped to uncover how some people avoid getting sick.
Long COVID leaves telltale traces in the blood
People with long COVID have distinct patterns of inflammation detectable in the blood, which could potentially be targeted with immune therapies.
5
Global human challenge consortium to push for next generation of vaccines
An international group of researchers specialising in human challenge studies is embarking on a project to develop advanced virus-blocking vaccines.
Major study shows new insights into lasting impacts of COVID‐19 on UK population
Tens of thousands of people in England may have lasting symptoms from COVID‐19 more than a year
after infection, new analysis reveals.
New multi-million research projects announced to tackle future disease threats
Imperial scientists are among those to lead ambitious new UK-based research to kickstart future vaccine development.
Imperial researchers and Moderna partner to help children affected by orphanhood
Research will improve how children affected by orphanhood receive the support they need to lead healthy and fulfilling lives now and into adulthood.
COVID-19 human challenge study reveals more insights into how virus spreads
New analysis shows how the SARS-CoV-2 virus spreads from the nose to the air and surfaces in the immediate surroundings.
Audio
Podcast: Analysing Trump voters, Jupiter mission launch, and COVID oximeter test
In this edition: What links Trump voters, how we’re going to investigate Jupiter’s moons, and why it’s a good idea to ask if a medical trial is fair.
Imperial to advise UN Economic and Social Council on reducing world inequalities
Imperial has been awarded consultative status at the UN Economic and Social Council (ECOSOC).
Delaying second doses of vaccine reduced COVID-19 hospitalisations and deaths
Delaying people’s second COVID-19 vaccine dose likely prevented tens of thousands of hospitalisations and thousands of deaths in England.